Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva
Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva
Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva
Submitted by
admin
on July 13, 2017 - 8:53am
Source:
Endpoints
News Tags:
AstraZeneca
Pascal Soriot
Pharma CEOs
Teva Pharmaceutical
Headline:
Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva
Do Not Allow Advertisers to Use My Personal information
